Experimental cancer treatment

This is an old revision of this page, as edited by Magnus Manske (talk | contribs) at 09:12, 1 December 2001 (There should be dozens more!). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Experimental cancer treatments are medical therapies to treat cancer (see also tumor) without the disadvantages of the standard therapies:

  • Removal of the cancer by a sugreon

The entries listed here vary between theoretical therapies and treatments that will most likely become standard procedures within the next few years. Many of these treatments will only help against specific forms of cancer. It is not a list of treatments widely available at hospitals!


Endostatin-based treatments

Every solid tumor (in contrast to liquid tumors like leucemia) needs to generate blood vessels to keep it alive once it reaches a certain size. Usually, blood vessels are not build elsewhere in an adult body. The anti-angiogenesis agent endostatin and related chemicals can suppress the building of blood vessels, preventing the cancer from growing indefinitely. In tests with patients, the tumor became inactive and stayed that way even after the endostatin treatment was finished. The treatment has very few side effects.